A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE)
Summary
- Eligibility
- for people ages 40 years and up (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Peyman Benharash, MD, FACS

Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Peyman Benharash, MD, FACS
Professor-in-residence, Surgery, Medicine. Authored (or co-authored) 444 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Genentech, Inc.
- Links
- Sign up for this study
- ID
- NCT06602453
- Phase
- Phase 2 Acute Kidney Injury Research Study
- Study Type
- Interventional
- Participants
- Expecting 404 study participants
- Last Updated